Protagen AG - Product Pipeline Analysis, 2017 Update

Summary

Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The companys products include multilisa Ssc, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyelitis optica, systemic lupus erythematosus, systemic sclerosis, multiple sclerosis and ankylosing spondylitis. Protagens technology comprise SeroTag, which enables differential diagnosis and patient stratification in various diseases. The company also develops companion diagnostics to pharmaceutical and biotechnology companies. The company partners with various educational organization and other healthcare companies. It markets its products through its network of distributors. Protagen is headquartered in Dortmund, Germany.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Protagen AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Protagen AG Company Overview 6
Protagen AG Company Snapshot 6
Protagen AG Pipeline Products and Ongoing Clinical Trials Overview 6
Protagen AG Pipeline Analysis Overview 9
Protagen AG - Key Facts 9
Protagen AG - Major Products and Services 10
Protagen AG Pipeline Products by Development Stage 11
Protagen AG Pipeline Products Overview 13
Diagnostic Assay - Alzheimers Disease 13
Diagnostic Assay - Alzheimers Disease Product Overview 13
Diagnostic Assay - Ankylosing Spondylitis 14
Diagnostic Assay - Ankylosing Spondylitis Product Overview 14
Diagnostic Assay - Breast Cancer 15
Diagnostic Assay - Breast Cancer Product Overview 15
Diagnostic Assay - Colon Cancer 16
Diagnostic Assay - Colon Cancer Product Overview 16
Diagnostic Assay - Juvenile Idiopathic Arthritis 17
Diagnostic Assay - Juvenile Idiopathic Arthritis Product Overview 17
Diagnostic Assay - Multiple Sclerosis 18
Diagnostic Assay - Multiple Sclerosis Product Overview 18
Diagnostic Assay - Neuromyelitis Optica 19
Diagnostic Assay - Neuromyelitis Optica Product Overview 19
Diagnostic Assay - Ovarian Cancer 20
Diagnostic Assay - Ovarian Cancer Product Overview 20
Diagnostic Assay - Pancreatic Cancer 21
Diagnostic Assay - Pancreatic Cancer Product Overview 21
Diagnostic Assay - Parkinsons Disease 22
Diagnostic Assay - Parkinsons Disease Product Overview 22
Diagnostic Assay - Prostate Cancer 23
Diagnostic Assay - Prostate Cancer Product Overview 23
Diagnostic Assay - Thyroid Disease 24
Diagnostic Assay - Thyroid Disease Product Overview 24
Diagnostic Assay - Type 1 Diabetes 25
Diagnostic Assay - Type 1 Diabetes Product Overview 25
Multilisa RA 26
Multilisa RA Product Overview 26
Multilisa SLE 27
Multilisa SLE Product Overview 27
Multiplex Assay - Autoimmune Disease 28
Multiplex Assay - Autoimmune Disease Product Overview 28
Multiplex Assay - Cancer 29
Multiplex Assay - Cancer Product Overview 29
NavigAID - Sjogrens Syndrome 30
NavigAID - Sjogrens Syndrome Product Overview 30
NavigAID Cancer 31
NavigAID Cancer Product Overview 31
NavigAID Rheumatoid Arthritis 32
NavigAID Rheumatoid Arthritis Product Overview 32
Protagen Diagnostic Assay - Endometriosis 33
Protagen Diagnostic Assay - Endometriosis Product Overview 33
Protagen AG - Key Competitors 34
Protagen AG - Key Employees 35
Protagen AG - Locations And Subsidiaries 36
Head Office 36
Recent Developments 37
Protagen AG, Recent Developments 37
Feb 02, 2017: Protagen join forces with the U.S. National Cancer Institute to answer pressing questions in immuno-oncology 37
Dec 13, 2016: PROTAGEN Launches NavigAID Assay to Support Clinical Drug Development for Autoimmune Diseases 37
Jul 20, 2016: Protagen Appoints Bernhard Kirschbaum as New Chairman and Oliver Schacht as New Board Member 38
Jun 15, 2016: Protagen announces CE Mark for its proprietary Multilisa BICD2 test for better diagnosis of Systemic Sclerosis 38
May 31, 2016: Protagen launches first CE marked diagnostic assay Multilisa Scl-70 for the diagnosis of Systemic Sclerosis 38
May 31, 2016: Protagen Launches First CE Marked Diagnostic Assay Multilisa CENP-B For The Diagnosis Of Systemic Sclerosis 39
Feb 11, 2016: Protagen supports novel route to serum based Prostate Cancer Diagnostics 39
Jan 21, 2016: Protagen AG Joins RA-MAP Consortium to Support Identification of Predictors of Remission in Rheumatoid Arthritis 40
Dec 10, 2015: Protagen Establishes Scientific Advisory Board 40
Nov 16, 2015: Protagen Launches Multilisa BICD2 Offering New Options in Diagnosing Systemic Sclerosis 41
Appendix 42
Methodology 42
About GlobalData 44
Contact Us 44
Disclaimer 44

List Of Tables


Protagen AG Pipeline Products and Ongoing Clinical Trials Overview 6
Protagen AG Pipeline Products by Equipment Type 7
Protagen AG Pipeline Products by Indication 8
Protagen AG, Key Facts 9
Protagen AG, Major Products and Services 10
Protagen AG Number of Pipeline Products by Development Stage 11
Protagen AG Pipeline Products Summary by Development Stage 12
Diagnostic Assay - Alzheimers Disease - Product Status 13
Diagnostic Assay - Alzheimers Disease - Product Description 13
Diagnostic Assay - Ankylosing Spondylitis - Product Status 14
Diagnostic Assay - Ankylosing Spondylitis - Product Description 14
Diagnostic Assay - Breast Cancer - Product Status 15
Diagnostic Assay - Breast Cancer - Product Description 15
Diagnostic Assay - Colon Cancer - Product Status 16
Diagnostic Assay - Colon Cancer - Product Description 16
Diagnostic Assay - Juvenile Idiopathic Arthritis - Product Status 17
Diagnostic Assay - Juvenile Idiopathic Arthritis - Product Description 17
Diagnostic Assay - Multiple Sclerosis - Product Status 18
Diagnostic Assay - Multiple Sclerosis - Product Description 18
Diagnostic Assay - Neuromyelitis Optica - Product Status 19
Diagnostic Assay - Neuromyelitis Optica - Product Description 19
Diagnostic Assay - Ovarian Cancer - Product Status 20
Diagnostic Assay - Ovarian Cancer - Product Description 20
Diagnostic Assay - Pancreatic Cancer - Product Status 21
Diagnostic Assay - Pancreatic Cancer - Product Description 21
Diagnostic Assay - Parkinsons Disease - Product Status 22
Diagnostic Assay - Parkinsons Disease - Product Description 22
Diagnostic Assay - Prostate Cancer - Product Status 23
Diagnostic Assay - Prostate Cancer - Product Description 23
Diagnostic Assay - Thyroid Disease - Product Status 24
Diagnostic Assay - Thyroid Disease - Product Description 24
Diagnostic Assay - Type 1 Diabetes - Product Status 25
Diagnostic Assay - Type 1 Diabetes - Product Description 25
Multilisa RA - Product Status 26
Multilisa RA - Product Description 26
Multilisa SLE - Product Status 27
Multilisa SLE - Product Description 27
Multiplex Assay - Autoimmune Disease - Product Status 28
Multiplex Assay - Autoimmune Disease - Product Description 28
Multiplex Assay - Cancer - Product Status 29
Multiplex Assay - Cancer - Product Description 29
NavigAID - Sjogrens Syndrome - Product Status 30
NavigAID - Sjogrens Syndrome - Product Description 30
NavigAID Cancer - Product Status 31
NavigAID Cancer - Product Description 31
NavigAID Rheumatoid Arthritis - Product Status 32
NavigAID Rheumatoid Arthritis - Product Description 32
Protagen Diagnostic Assay - Endometriosis - Product Status 33
Protagen Diagnostic Assay - Endometriosis - Product Description 33
Protagen AG, Key Employees 35
Glossary 43

List Of Figures


Burmeister & Wain Scandinavian Contractor A/S, Power, Deals By Year, 2011 to YTD 2017 22
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals by Type, 2011 to YTD 2017 23

Protagen AG - Product Pipeline Analysis, 2020 Update

Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The companys products include multilisa SSC, multilisa SLE and multilisa RA. It provides

USD 750 View Report

Protagen AG - Medical Equipment - Deals and Alliances Profile.

Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The companys products include multilisa Ssc, multilisa SLE and multilisa RA. It provides

USD 250 View Report

Benteler International AG - Strategy, SWOT and Corporate Finance Report

Benteler International AG - Strategy, SWOT and Corporate Finance ReportBenteler International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

RUAG International Holding AG - Strategy, SWOT and Corporate Finance Report

RUAG International Holding AG - Strategy, SWOT and Corporate Finance ReportRUAG International Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information.

USD 175 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available